Kosmatopoulos K, Orbach-Arbouys S
J Immunol. 1987 Feb 1;138(3):704-12.
Hybrid resistance, which is observed in certain strain combinations when parent-strain bone marrow cells are grafted into lethally irradiated F1 hybrids, can be specifically overcome by the i.v. injection, 1 wk before the graft, of spleen cells syngeneic with the bone marrow graft. This phenomenon is due to a suppressor mechanism, induced in the spleen of the F1 hybrid by the injection of parent-strain spleen cells and mediated by a nylon-adherent Thy-1+Lyt-1+2- cell population of hybrid origin, because hybrid resistance can be inhibited by the transfer into a normal B6D2F1 of nylon-adherent Thy-1+Lyt-1+2- spleen cells from B6D2F1 mice pretreated with B6 spleen cells 1 wk earlier (B6-pretreated B6D2F1); spleen cells from B6-pretreated B6D2F1 mice not depleted of their nylon-adherent subpopulation cannot restore hybrid resistance when they are injected into a B6D2F1 rendered nonresistant by split-dose irradiation; and spleen cells from normal B6D2F1 mice cannot restore hybrid resistance when they are injected into B6-pretreated B6D2F1 hybrids. The suppressor cells specifically inhibit resistance against bone marrow cells syngeneic with the spleen cells used for pretreatment, because transfer of nylon-adherent B6-pretreated B6D2F1 spleen cells into a normal B6D2F1 does not enhance syngeneic B6D2F1 or parent-strain D2 bone marrow growth, and when injected into normal B6D2F1 hybrids, nylon-adherent spleen cells from B6D2F1 mice pretreated with D2 spleen cells 1 wk earlier (D2-pretreated B6D2F1) are not able to transfer the inhibition of hybrid resistance against B6 bone marrow cells. Moreover, the activity of the suppressor cells depends on the genetic environment of the hybrid host mice, because nylon-adherent B6-pretreated B6D2F1 spleen cells injected into normal B6C3F1 hybrids do not transfer an inhibition of hybrid resistance, and when injected into B6C3F1 hosts previously rendered nonresistant by split-dose irradiation, spleen cells from B6-pretreated B6D2F1 mice can, in contrast, transfer hybrid resistance.
杂种抗性是指当亲本品系的骨髓细胞移植到经致死剂量照射的F1杂种小鼠体内时,在某些品系组合中所观察到的现象。在移植前1周静脉注射与骨髓移植同系的脾细胞,可特异性地克服这种杂种抗性。这种现象是由于一种抑制机制引起的,该机制由亲本品系脾细胞注射诱导产生于F1杂种小鼠的脾脏中,并由杂种来源的尼龙粘附性Thy-1+Lyt-1+2-细胞群体介导。因为将1周前用B6脾细胞预处理的B6D2F1小鼠的尼龙粘附性Thy-1+Lyt-1+2-脾细胞转移到正常的B6D2F1小鼠中,可抑制杂种抗性;将未去除尼龙粘附亚群的B6预处理的B6D2F1小鼠的脾细胞注射到经分次照射而无抗性的B6D2F1小鼠中,不能恢复杂种抗性;将正常B6D2F1小鼠的脾细胞注射到B6预处理的B6D2F1杂种小鼠中,也不能恢复杂种抗性。抑制细胞特异性地抑制对与用于预处理的脾细胞同系的骨髓细胞的抗性,因为将尼龙粘附的B6预处理的B6D2F1脾细胞转移到正常的B6D2F1小鼠中,不会增强同系B6D2F1或亲本品系D2骨髓的生长,并且当注射到正常的B6D2F1杂种小鼠中时,1周前用D2脾细胞预处理的B6D2F1小鼠的尼龙粘附脾细胞不能转移对B6骨髓细胞的杂种抗性抑制作用。此外,抑制细胞的活性取决于杂种宿主小鼠的遗传环境,因为将尼龙粘附的B6预处理的B6D2F1脾细胞注射到正常的B6C3F1杂种小鼠中,不会转移杂种抗性抑制作用,而当注射到先前经分次照射而无抗性的B6C3F1宿主中时,相反,B6预处理的B6D2F1小鼠的脾细胞可以转移杂种抗性。